FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas.
Grupp K, Uzunoglu FG, Melling N, Hofmann B, El Gammal AT, Grotelüschen R, Heumann A, Bellon E, Reeh M, Wolters-Eisfeld G, Ghabdan T, Nentwich M, Bachmann K, Bockhorn M, Bogoevski D, Izbicki JR, Kutup A.
Grupp K, et al. Among authors: groteluschen r.
Sci Rep. 2018 Nov 26;8(1):17370. doi: 10.1038/s41598-018-35459-4.
Sci Rep. 2018.
PMID: 30478420
Free PMC article.